On the Frontlines of ATTR-CM
Welcome to On the Frontlines of ATTR-CM, a series that delivers timely, practice-relevant insights from leading experts who are shaping the field. So whether you’re sharpening your diagnostic skills or staying ahead of therapeutic advances, tune in to gain knowledge that can help transform patient outcomes.
1-7 of 7
Patient Voices in ATTR-CM: Driving Change in Diagnosis, Referral, and Support
On the Frontlines of ATTR-CMPatient Voices in ATTR-CM: Driving Change in Diagnosis, Referral, and Support
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
On the Frontlines of ATTR-CMExploring Patient Perspectives on Genetic Testing for ATTR-CM
Managing Genotype-Positive Patients in Hereditary ATTR-CM
On the Frontlines of ATTR-CMManaging Genotype-Positive Patients in Hereditary ATTR-CM
The Cost of Progress: Examining Barriers to ATTR-CM Care
On the Frontlines of ATTR-CMThe Cost of Progress: Examining Barriers to ATTR-CM Care
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
On the Frontlines of ATTR-CMVutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
Advances in Care for ATTR-CM: Current and Emerging Strategies
Heart MattersAdvances in Care for ATTR-CM: Current and Emerging Strategies
- advertisement
Patient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Heart MattersPatient Case: ATTRwt-CM Discovered Decades After Heart Transplant
